Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P4
Near historical low
vs 2Y Ago
-0.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -143.88% |
| Q3 2025 | 374.00% |
| Q2 2025 | 22.65% |
| Q1 2025 | -136.57% |
| Q4 2024 | 701.78% |
| Q3 2024 | 28.18% |
| Q2 2024 | 24.68% |
| Q1 2024 | -241.52% |
| Q4 2023 | 205.99% |
| Q3 2023 | 17.02% |
| Q2 2023 | 2.49% |
| Q1 2023 | -4.34% |
| Q4 2022 | -41.86% |
| Q3 2022 | 4.50% |
| Q2 2022 | 20.41% |
| Q1 2022 | -67.45% |
| Q4 2021 | 11.51% |
| Q3 2021 | -20.06% |
| Q2 2021 | -1.57% |
| Q1 2021 | -64.26% |
| Q4 2020 | -24.79% |
| Q3 2020 | -42.93% |
| Q2 2020 | -61.46% |
| Q1 2020 | 0.00% |